Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
0.6%
1w
2.8%
1m
8.7%
3m
28.6%
6m
36.4%
1y
27.7%
all
14.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 572 0.6%
410
624
Company Overview

Sales
947 Cr
Growth: 0.8%
Profit after Tax
248 Cr
Growth: -15.6%
Mid Cap
10,836 Cr
P/E: 40.0x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 947
Growth 0.8%
EBITDA 31.0%
P/S 11.4x
Dividend 0.2%
P/E 40.0x
Book Value ₹ 71.8
PEG Ratio 53.1x
ROE 19.1%
P/B 8.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)